India, March 9 -- In a collaborative effort led by the University of Alabama at Birmingham Marnix E. Heersink School of Medicine, researchers examining how the evaluation of cholesterol levels, awareness of high cholesterol levels, and lipid-lowering therapy varied between 2011 and 2020 among individuals with severe dyslipidemia found that only one in three individuals with severe dyslipidemia took statins, in a recent study published in the Mayo Clinic Proceedings.
Dyslipidemia refers to unhealthy levels of certain lipids, or fats, in the blood. With dyslipidemia, it usually means that low-density lipoprotein cholesterol levels, also known as bad cholesterol levels, are too high.
"Severe dyslipidemia, or elevated LDL cholesterol level...